BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

516 related articles for article (PubMed ID: 31272438)

  • 1. Fueling the fire: emerging role of the hexosamine biosynthetic pathway in cancer.
    Akella NM; Ciraku L; Reginato MJ
    BMC Biol; 2019 Jul; 17(1):52. PubMed ID: 31272438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epithelial Mesenchymal Transition Induces Aberrant Glycosylation through Hexosamine Biosynthetic Pathway Activation.
    Lucena MC; Carvalho-Cruz P; Donadio JL; Oliveira IA; de Queiroz RM; Marinho-Carvalho MM; Sola-Penna M; de Paula IF; Gondim KC; McComb ME; Costello CE; Whelan SA; Todeschini AR; Dias WB
    J Biol Chem; 2016 Jun; 291(25):12917-29. PubMed ID: 27129262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hexosamine biosynthetic pathway promotes the antiviral activity of SAMHD1 by enhancing O-GlcNAc transferase-mediated protein O-GlcNAcylation.
    Hu J; Gao Q; Yang Y; Xia J; Zhang W; Chen Y; Zhou Z; Chang L; Hu Y; Zhou H; Liang L; Li X; Long Q; Wang K; Huang A; Tang N
    Theranostics; 2021; 11(2):805-823. PubMed ID: 33391506
    [No Abstract]   [Full Text] [Related]  

  • 4. The hexosamine biosynthetic pathway and cancer: Current knowledge and future therapeutic strategies.
    Lam C; Low JY; Tran PT; Wang H
    Cancer Lett; 2021 Apr; 503():11-18. PubMed ID: 33484754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First characterization of glucose flux through the hexosamine biosynthesis pathway (HBP) in
    Olson AK; Bouchard B; Zhu WZ; Chatham JC; Des Rosiers C
    J Biol Chem; 2020 Feb; 295(7):2018-2033. PubMed ID: 31915250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysregulation of hexosamine biosynthetic pathway wiring metabolic signaling circuits in cancer.
    Itano N; Iwamoto S
    Biochim Biophys Acta Gen Subj; 2023 Jan; 1867(1):130250. PubMed ID: 36228878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hexosamine biosynthetic pathway and
    Kim DY; Park J; Han IO
    Am J Physiol Cell Physiol; 2023 Oct; 325(4):C981-C998. PubMed ID: 37602414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bittersweet tumor development and progression: Emerging roles of epithelial plasticity glycosylations.
    Phillips RM; Lam C; Wang H; Tran PT
    Adv Cancer Res; 2019; 142():23-62. PubMed ID: 30885363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Hexosamine Biosynthesis Pathway: Regulation and Function.
    Paneque A; Fortus H; Zheng J; Werlen G; Jacinto E
    Genes (Basel); 2023 Apr; 14(4):. PubMed ID: 37107691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insights: A role for O-GlcNAcylation in diabetic complications.
    Peterson SB; Hart GW
    Crit Rev Biochem Mol Biol; 2016; 51(3):150-61. PubMed ID: 26806492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticancer Properties of Hexosamine Analogs Designed to Attenuate Metabolic Flux through the Hexosamine Biosynthetic Pathway.
    Saeui CT; Shah SR; Fernandez-Gil BI; Zhang C; Agatemor C; Dammen-Brower K; Mathew MP; Buettner M; Gowda P; Khare P; Otamendi-Lopez A; Yang S; Zhang H; Le A; QuinoƱes-Hinojosa A; Yarema KJ
    ACS Chem Biol; 2023 Jan; 18(1):151-165. PubMed ID: 36626752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Hexosamine Biosynthetic Pathway as a Therapeutic Target after Cartilage Trauma: Modification of Chondrocyte Survival and Metabolism by Glucosamine Derivatives and PUGNAc in an Ex Vivo Model.
    Riegger J; Baumert J; Zaucke F; Brenner RE
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutamine deprivation triggers NAGK-dependent hexosamine salvage.
    Campbell S; Mesaros C; Izzo L; Affronti H; Noji M; Schaffer BE; Tsang T; Sun K; Trefely S; Kruijning S; Blenis J; Blair IA; Wellen KE
    Elife; 2021 Nov; 10():. PubMed ID: 34844667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probing the hexosamine biosynthetic pathway in human tumor cells by multitargeted tandem mass spectrometry.
    Abdel Rahman AM; Ryczko M; Pawling J; Dennis JW
    ACS Chem Biol; 2013 Sep; 8(9):2053-62. PubMed ID: 23875632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hexosamines, insulin resistance, and the complications of diabetes: current status.
    Buse MG
    Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E1-E8. PubMed ID: 16339923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting Protein
    Bolanle IO; Palmer TM
    Cells; 2022 Feb; 11(4):. PubMed ID: 35203353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hexosamine Biosynthetic Pathway-Derived O-GlcNAcylation Is Critical for RANKL-Mediated Osteoclast Differentiation.
    Kim MJ; Kim HS; Lee S; Min KY; Choi WS; You JS
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Azide- and Alkyne-Bearing Metabolic Chemical Reporters of Glycosylation Show Structure-Dependent Feedback Inhibition of the Hexosamine Biosynthetic Pathway.
    Walter LA; Batt AR; Darabedian N; Zaro BW; Pratt MR
    Chembiochem; 2018 Sep; 19(18):1918-1921. PubMed ID: 29979493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Nutrient-Sensing Hexosamine Biosynthetic Pathway as the Hub of Cancer Metabolic Rewiring.
    Chiaradonna F; Ricciardiello F; Palorini R
    Cells; 2018 Jun; 7(6):. PubMed ID: 29865240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On a sugar high: Role of O-GlcNAcylation in cancer.
    Le Minh G; Esquea EM; Young RG; Huang J; Reginato MJ
    J Biol Chem; 2023 Nov; 299(11):105344. PubMed ID: 37838167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.